SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: DMaA who wrote (606669)9/1/2016 12:48:54 PM
From: DewDiligence_on_SI  Respond to of 793858
 
The problem with Coumadin is it is so difficult to titrate the dose to get the blood thickness you want.
Right.
Is this not such a big issue with the new drugs?
Correct. The new Factor-Xa inhibitors have a much wider "therapeutic window" in which they inhibit clotting without causing bleeds.



To: DMaA who wrote (606669)9/1/2016 1:00:20 PM
From: Bearcatbob1 Recommendation

Recommended By
skinowski

  Respond to of 793858
 
One of the great days of my life was when I no longer had to take the crap.



To: DMaA who wrote (606669)9/1/2016 1:42:33 PM
From: Copeland  Respond to of 793858
 
No, the new drugs, Xarelto and Eliquis don't require dose adjustment. The issue is reversal. You can easily reverse coumadin; it's a real PIA to reverse xarelto and eliquis. I have lost many people to hemorrhagic strokes that I could not reverse because they were on those drugs, but that's probably revealing too much information about my outside of SI life.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News